LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Silexion Therapeutics Corp

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERSLXN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / SLXN COVERAGE

What’s moving Silexion Therapeutics Corp now

Current reporting with the operating signal separated from the noise.

01
MarketBeat

Top Silexion Therapeutics Corp - Warrant (SLXNW) Competitors 2026

The story matters when it changes Silexion Therapeutics Corp’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
dars.gov.et

Silexion Therapeutics Corp Warrant (SLXNW) Holds Near Par After Modest Decline - Profit Surge Picks

Investors are testing whether Silexion Therapeutics Corp’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
TradingView

Silexion Therapeutics Corp Revenue Breakdown – NASDAQ:SLXNW

Investors are testing whether Silexion Therapeutics Corp’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
TradingKey

Silexion Therapeutics Corp (SLXN) Risk Assessment: Volatility, Financial Risk & Investment Risk

The story matters when it changes Silexion Therapeutics Corp’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
TradingKey

Silexion Therapeutics Corp (SLXN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

Investors are testing whether Silexion Therapeutics Corp’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
Silexion Therapeutics Corp. Announces $3.3 Million Warrant Exercise and New Private Placement Financing

Silexion Therapeutics Corp. Announces $3.3 Million Warrant Exercise and New Private Placement Financing

The story matters when it changes Silexion Therapeutics Corp’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest SLXN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-12 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-05-19 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-31 · Period 2026-07-31SEC ↗8-KMaterial company eventFiled 2026-07-29 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-07-21 · Period 2026-07-21SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-06-16 · Period 2026-06-16SEC ↗DEFA14AOfficial SEC filingFiled 2026-07-13SEC ↗
EARNINGS / QUARTERLY TRACKER

Silexion Therapeutics Corp, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.